Assistant Professor
Brigham and Women's Hospital
Boston, MA, US
Pier Paolo Peruzzi, MD, PhD, is an Assistant Professor of Neurosurgery at the Brigham and Women’s Hospital in Boston and Principal Investigator in the Harvey Cushing Neuro-oncology Laboratories at Harvard Medical School.
He attended medical school in Rome, Italy, and received his neurosurgery training at the Ohio State University, where he also obtained a PhD in molecular biology.
Dr Peruzzi is primarily focused on the care of patients with primary brain tumors and advancing therapies both at the clinical and basic research levels.
His molecular biology laboratory investigates the role of non-coding RNAs in malignant brain tumors, with a particular interest in exploiting their biological properties to modulate the tumor epigenetic landscape and adaptive response to therapy. For his work, he has received a K12 and K08 Career Development Award from NIH in 2016 and 2017, respectively, followed by an R01 in 2020 and a second one in 2023. He has also been the recipient of the Neurosurgery Research and Education Foundation Award in 2011, the American Academy of Neurological Surgery Award in 2018, the Distinguished Scientist Award by the Sontag Foundation in 2020 and the Disruptive Dozen award at the 2022 World Medical Innovation Forum.
In clinics, Dr Peruzzi is the principal investigator for a multicenter trial studying the use of drug-releasing microdevices for in situ, patient-specific characterization of tumor sensitivity to different chemotherapics. This work is currenlty funded by an R01 and the collaborative research award by ABTA.
In 2022 he co-founded and is in the board of directors of Ternalys Therapeutics, a gene therapy biotech startup which focuses on RNA-based therapy for cancer.
Disclosure(s): Ternalys Therapeutics: Stock Shareholder (excluding mutual funds) (Ongoing)
Personalized Medicine: Microdevices for In-Vivo Therapeutic Evaluation
Monday, May 6, 2024
10:45 AM – 11:05 AM CT